Article

Case Report: Fatal myocarditis after combination of immune checkpoint inhibitor and platinum doublet chemotherapy

2021-01-18

Abstract excerpt

Myocarditis is a rare but feared adverse event of treatment with immune checkpoint inhibitors. The incidence is about 1%, while the mortality rate is up to 50%. Many physicians treating lung cancer do not have experience with this serious adverse event, and few hospitals in Scandinavia have routines for baseline assessments that may help detect early signs of inflammation of the myocard. Early onset of anti-inflam...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 29d6d9a6-ca15-511b-9b82-b15eea9949f1
DOI: 10.12688/f1000research.27967.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Case Report: Fatal myocarditis after combination of immune checkpoint inhibitor and platinum doublet chemotherapyDOI 10.12688/f1000research.27967.1Read

Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositisSemantic proximity Read

Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of TreatmentSemantic proximity Read

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeveritySemantic proximity Read

Cardiotoxicity Associated with Targeted Therapies in Lung Cancer: A Retrospective Cohort Study of 2,427 Patients with FAERS Pharmacovigilance ValidationSemantic proximity Read

Trousseau's syndrome triggered by an immune checkpoint blockade in a non‐small cell lung cancer patientSemantic proximity Read

18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditisSemantic proximity Read

A case of Brugada phenocopy alteration induced by immune checkpoint inhibitors.Semantic proximity Read

Development of Complete Atrioventricular Block Following the Administration of the COVID-19 vaccine in a Young Patient: a Case ReportSemantic proximity Read

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosisSemantic proximity Read

Management of nonbacterial thrombotic endocarditis (NBTE) in advanced non-small cell lung cancer (NSCLC) patients with driver mutation: two case reports.Semantic proximity Read

Pulmonary Embolism And Bradycardia in a NSCLC Patient Treated With Crizotinib For a Rare Mutation: A Case ReportSemantic proximity Read

Reduction of pericardial effusion in advanced non-small cell lung cancer patients with KRAS, TP53, and MET mutation treated with nivolumab.Semantic proximity Read